Evelyn Partners’s Organon & Co OGN Stock Holding History

Evelyn Partners’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$311	Buy	+23	New	+$275	﹤0.01%	538

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Evelyn Partners's OGN Position: Q2 2026 in Review

Evelyn Partners opened a new position in Organon & Co (OGN) in Q2 2026: 23 shares worth $311. The stake represents ﹤0.01% of the portfolio and ranks #538 among its holdings.

594 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Evelyn Partners held 23 shares of Organon & Co worth $311 as of Q2 2026.
Organon & Co was a new Evelyn Partners position in Q2 2026.
Organon & Co made up ﹤0.01% of Evelyn Partners's portfolio in Q2 2026, its #538 holding.
594 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Evelyn Partners's 13F filing for Q2 2026, filed 7 Aug 2026.